Challenges with implementing CAR-T approaches in solid tumors

Challenges with implementing CAR-T approaches in solid tumors

Challenges in the development of CAR-T approaches for patients with gliomaПодробнее

Challenges in the development of CAR-T approaches for patients with glioma

CAR-T in solid tumors: challenges and future directionsПодробнее

CAR-T in solid tumors: challenges and future directions

Moffitt Medical Minute: CAR T Cell Therapy for Solid Tumor CancerПодробнее

Moffitt Medical Minute: CAR T Cell Therapy for Solid Tumor Cancer

ESGCT e-Seminar: Combining Oncolytic Viruses and CAR-T TherapiesПодробнее

ESGCT e-Seminar: Combining Oncolytic Viruses and CAR-T Therapies

The challenges in implementing CAR-T cell therapy for the treatment of solid tumorsПодробнее

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene TherapyПодробнее

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28ζ T cellsПодробнее

Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28ζ T cells

Targeting Tumor Mutations for Personalized Cancer ImmunotherapyПодробнее

Targeting Tumor Mutations for Personalized Cancer Immunotherapy

Dissecting the tumor microenvironment – tools for cell isolation and flow analysis [WEBINAR]Подробнее

Dissecting the tumor microenvironment – tools for cell isolation and flow analysis [WEBINAR]

Development of a Semi-Automated Closed CAR-T Manufacturing ProcessПодробнее

Development of a Semi-Automated Closed CAR-T Manufacturing Process

Engineering T cells: moving beyond leukemiaПодробнее

Engineering T cells: moving beyond leukemia

Michael Milone - Immunotherapy of Cancer Using Genetically Enhanced T CellsПодробнее

Michael Milone - Immunotherapy of Cancer Using Genetically Enhanced T Cells

События